News

Paul Welzl, joint PhD student in the Plaschka and Balzarotti labs at the Research Institute of Molecular Pathology (IMP), was awarded a prestigious…

29 Jul'24

The chaperone UNC45, crucial for muscle health, directs myosin—key for movement—toward removal or assembly pathways. The Clausen lab at the Research…

15 Jul'24

Francisco Balzarotti, Group Leader at the Research Institute of Molecular Pathology (IMP) was awarded a 2024 Frontiers of Science Award for his…

09 Jul'24

In EMBO's 60th anniversary year, 100 new Members and 20 Associate Members from 37 countries and territories join the community. The EMBO Membership…

07 Jul'24

Grigory Genikhovich, Sylvia Kirchengast and Gerhard Weber have received new funding from the Austrian Science Fund (FWF). In their respective…

05 Jul'24

In a collaborative effort drawing from scientists across the Vienna BioCenter, researchers from the Research Institute of Molecular Pathology (IMP),…

04 Jul'24

Kevin Sabath, postdoctoral researcher in the labs of Alexander Stark and Clemens Plaschka at the Research Institute of Molecular Pathology (IMP), was…

02 Jul'24

The Austrian Academy of Sciences (ÖAW) has awarded one of its competitive DOC Fellowships to David Hollaus, PhD student at the lab of Moritz Gaidt at…

01 Jul'24

Antagonists that are themselves antagonized play a common regulatory role in molecular biology. Peter Schlögelhofer, along with first author Ignacio…

01 Jul'24

Valneva announced that the European Commission (EC) has granted marketing authorization in Europe for Valneva’s single-dose vaccine, IXCHIQ^®, for the…

28 Jun'24